Search clinical trials for: Pazopanib (GW786034)
Total 302 results
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States
-
Case Comprehensive Cancer CenterCompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
National Cancer Institute (NCI)WithdrawnSarcoma | Osteosarcoma | Brain Tumor | Neuroblastoma | Wilms TumorUnited States
-
Illinois CancerCare, P.C.TerminatedNon Small Cell Lung CancerUnited States
-
Washington University School of MedicineNovartisTerminatedNon-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell LungUnited States
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States
-
Illinois CancerCare, P.C.TerminatedProstate CancerUnited States
-
GlaxoSmithKlineCompletedSarcoma, Soft TissueBelgium, Netherlands, United Kingdom, France, Hungary
-
The Netherlands Cancer InstituteGlaxoSmithKlineCompletedSarcoma,Soft TissueNetherlands
-
Novartis PharmaceuticalsChildren's Oncology GroupCompletedSolid TumoursUnited States, Canada, Hungary, Spain, France, Slovakia, Czechia
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Australia
-
Washington University School of MedicineNovartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Sarcoma, Soft TissueUnited States
-
National Cancer Institute (NCI)CompletedNeoplasms | LymphomaUnited States
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Taiwan, Belgium, Israel, Australia, Hong Kong, China, Czech Republic
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States
-
Centre Leon BerardGlaxoSmithKlineCompletedThyroid CarcinomaFrance
-
GlaxoSmithKlineCompleted
-
Kathy MillerCompleted
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Netherlands
-
Associació per a la Recerca Oncologica, SpainTrial Form Support S.L.Unknown
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellItaly, Argentina, Korea, Republic of, Estonia, Hong Kong, Ukraine, Ireland, Latvia, Pakistan, China, Austria, Greece, New Zealand, Poland, Russian Federation, United Kingdom, Australia, India, Czech Republic, Mexico, Brazil, Chile, ... and more
-
GlaxoSmithKlineCompletedMacular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States, Canada, Spain, United Kingdom, Taiwan, Netherlands, Australia, Germany, Italy, Japan, Sweden, China, Ireland, Korea, Republic of
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellSingapore, United States
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; University of California, Los Angeles and other collaboratorsTerminatedSarcoma | Leiomyosarcoma | Malignant Peripheral Nerve Sheath Tumor | Malignant Fibrous | Histiocytoma/Undifferentiated Pleomorphic SarcomaUnited States
-
Sandy SrinivasGlaxoSmithKlineCompletedBladder Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
National Cancer Institute (NCI)TerminatedHigh Grade Sarcoma | Metastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated... and other conditionsUnited States
-
Novartis PharmaceuticalsMerck Sharp & Dohme LLCCompletedCarcinoma, Renal CellUnited States, United Kingdom
-
GlaxoSmithKlineCompletedMacular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States, Singapore, France, United Kingdom
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
City of Hope Medical CenterCompletedClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
GlaxoSmithKlineCompletedNon-Small Cell Lung Cancer | Lung Cancer, Non-Small CellUnited States, Spain, Israel
-
GlaxoSmithKlineCompletedCancer | Epithelial Ovarian Cancer | Tumor | Primary Peritoneal Carcinoma | Neoplasms, Ovarian | Uterine Disease | Cervix DiseasesFrance, Germany
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellDenmark, United Kingdom
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellGermany, United Kingdom
-
GlaxoSmithKlineCompletedMacular DegenerationUnited States
-
M.D. Anderson Cancer CenterCompleted
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, Italy
-
GlaxoSmithKlineNSABP Foundation IncCompleted
-
GlaxoSmithKlineCompletedMetastatic Cervical Cancer | Neoplasms, Uterine CervixUnited States, Germany, Spain, Thailand, Belgium, Italy, Argentina, Canada, Ireland, India, France, Estonia, Mexico
-
Vector OncologyGlaxoSmithKlineCompletedGynecologic TumorsUnited States
-
Northwestern UniversityGlaxoSmithKline; National Comprehensive Cancer Network; Robert H. Lurie Cancer...CompletedRecurrent Islet Cell Carcinoma | Pancreatic Alpha Cell Carcinoma | Pancreatic Beta Islet Cell Carcinoma | Pancreatic Delta Cell Carcinoma | Pancreatic G-cell CarcinomaUnited States
-
GlaxoSmithKlineCompletedMacular DegenerationUnited States
-
GlaxoSmithKlineWithdrawnHormone-receptor Positive Breast CancerUnited States